Investor Overview

Welcome to the MDS Investor Relations section. Here you will find the latest information on the value of MDS — from financial data and shareholder services, to reports and events.

Corporate Profile:

MDS (TSX: MDS; NYSE: MDZ), a global life sciences company with 2008 net revenues of US$1.2 billion, provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease.

The Company's three core businesses — MDS Analytical Technologies, MDS Nordion and MDS Pharma Services — are global industry leaders in analytical instruments, molecular imaging, and pharmaceutical contract research, respectively. These are robust and attractive markets.

MDS is focused on opportunities to strengthen the Company's position as a leading innovator in the global life sciences markets served by the Company's three core businesses.

MDS Analytical Technologies is a leading global supplier of life sciences tools focused on the research, design, manufacture and marketing of state-of-the-art solutions for mass spectrometry, drug discovery and bioresearch. It operates in an estimated US$6 billion market. Learn more.

MDS Nordion is a leading global provider of medical isotopes for molecular imaging, radiotherapeutics and sterilization technologies. It operates in an estimated US$4 billion market. Learn more.

MDS Pharma Services is a leading global provider of Early Stage pharmaceutical research services for pharmaceutical and biotechnology companies. MDS Pharma Services currently operates in an estimated US$5 billion market. Learn more.  

MDS was founded in 1969 and currently has more the 4,200 highly skilled people operating in 13 countries.

MDS trades on the Toronto Stock Exchange (TSX: MDS) and on the New York Stock Exchange (NYSE: MDZ).

Investment Thesis

MDS is a US$1.2 billion global life sciences company with three strong leading platforms in attractive markets.

Provider of innovative, high-quality products and services.

Customer-focused and performance-driven culture.

Appropriate balance of operating improvement, growth and investment.

Strong management with a proven track record of execution.